RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 20 - per page Next page
Order by
Instead Fertility Cup
Conception aid, fertility cup More
CollaRx® & LiquiColl® Technologies
Collagen-based biodegradable matrices for localized drug delivery More
Cold Fleece Patch
Adhesive patch containing and delivering essential and balsamic oils for the symptomatic treatment of the common cold and nasal congestion More
Aerosolized Vaccines
Aerosolized immunogenic compositions that may prove useful for vaccination against respiratory infections and may provide a platform for generating mucosal antibody responses against other pathogens. More
Chemoenzymatic synthesis of Tamiflu (oseltamivir) and/or Tamiflu derivatives
A novel chemoenzymatic method for producing a key building block of Tamiflu (oseltamivir). More
Botulinum Toxoid
A variety of new toxoids useful as botulinum vaccine antigens, for BAT or BIG production, or for development of tests to evaluate antigenicity of botulinum vaccines More
Modified Sugar Substrates and Methods of Use
Methods and compositions for making and using functionalized sugars More
Use of Biological Surfactant as Anti-flammatory Agent and Tissue Preservative Solution
Cancer immunotherapy using dendritic cells, and iii) Camel recombinant antibodies for FoxP3, Mucl & CEA. More
NexACT® multi-route drug delivery technology (esp. topical, oral, subcutaneous, buccal, and rectal)
NexACT(R) utilizes highly effective, novel excipients or “penetration enhancers” to dramatically improve absorption and bioavailability of drugs. Varying the concentration of the enhancer allows for local or systemic delivery of drug, as desired. More
Use of Saccharides Cross-Reactive with Bacillus anthracis Spore Glycoprotein as a Vaccine Against Anthrax
Use of Shewanella CPS conjugates as a component of an anthrax vaccine More
Displaying 1..10 of 20 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.innovaro.com
The National Institute of Allergy and Infectious Diseases – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
Infectious Diseases Pipeline Databook - November 2011
Nov 2011 - 7 pages - $3,835
Deals and alliances in infectious diseases
Jun 2006 - 1458 pages - $2,495
Chronic Diseases on the Rise: Personal Health Systems to Play a Key Role in Disease Management
Oct 2009 - 17 pages - $500
Point of Care Diagnostics for Emerging Infectious Disease Threats (Market Analysis and Technical Considerations)
Oct 2011 - 150 pages - $3,500
Will 2011 Spell a Brighter Year for the Pharmaceutical Companies?
Mar 2011 - 6 pages - $500
Infectious Disease Research Institute – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 28 pages - $500
The National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Mar 2011 - 32 pages - $250
Chugai Pharmaceutical Co., Ltd. - SWOT Analysis
Jun 2010 - 26 pages - $125
Chugai: Pipeline, Products, Performance, Potential
Oct 2009 - 80 pages - $1,040
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2012 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us